title: Treatment of depression in individuals living with HIV/AIDS.
abstract: BACKGROUND
  Depression is common in patients with HIV/AIDS, and can have an impact on quality of life, as well as various health outcomes. This study was designed to observe the efficacy of standard treatment of depression in human immunodeficiency virus (HIV) (+) individuals in an urban psychiatric clinic.
  
  
  METHODS
  This study consisted of a retrospective chart review of patients presenting for psychiatric services between January 1, 2008 and December 31, 2010. A total of 211 charts were examined for factors including diagnosis given at initial visit, health status, sociodemographic factors and comorbid illnesses, as well as treatment plan prescribed; of these, 132 patients were determined to be depressed at the initial evaluation (Beck Depression Inventory (BDI> 13) and to return for at least one follow-up visit.
  
  
  RESULTS
  Of the 132 depressed patients, 48 (36.4%) reached remission (BDI <13) at some point at follow-up, and an additional 12 (50.7%) achieved response (decrease in BDI of 50%). Remission correlated with having disability income and having a viral load that was not detectable.
  
  
  CONCLUSIONS
  Depression is common in HIV/AIDS, and is important to treat. Furthermore, individuals with depression and HIV/AIDS respond at rates similar to what is seen in other depressed populations.
authors: Stanford University, Department of Psychiatry and Behavioral Sciences, Stanford, CA 94305, USA. mprimeau@stanford.edu
authors: Michelle M
authors: MM
authors: Primeau
authors: Victoria
authors: V
authors: Avellaneda
authors: Dominique
authors: D
authors: Musselman
authors: Gilbert
authors: G
authors: St Jean
authors: Lourdes
authors: L
authors: Illa
mesh_terms: D000328:Adult; D000368:Aged; D044966:Anti-Retroviral Agents / Q000627:therapeutic use; D018791:CD4 Lymphocyte Count; D003131:Combined Modality Therapy; D003866:Depressive Disorder / Q000453:epidemiology* / Q000523:psychology / Q000628:therapy; D018450:Disease Progression; D005260:Female; D015658:HIV Infections / Q000453:epidemiology* / Q000523:psychology / Q000628:therapy; D006801:Humans; D018868:Insurance, Disability; D008297:Male; D055118:Medication Adherence / Q000523:psychology; D008875:Middle Aged; D011569:Psychiatric Status Rating Scales / Q000706:statistics & numerical data; D011613:Psychotherapy / Q000706:statistics & numerical data; D012042:Registries; D012074:Remission Induction; D012189:Retrospective Studies; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use; D012720:Severity of Illness Index; D016896:Treatment Outcome; D019562:Viral Load; D055815:Young Adult
chemical_list: D044966:Anti-Retroviral Agents; D017367:Selective Serotonin Reuptake Inhibitors